SCHEMBL5599670

SCHEMBL5599670

C=C(C)CC1N(C(=O)Nc2ccc(OC)cc2)c2ccccc2C12CCNCC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.44
CYP3A4 P08684 1/20 0.44
MAPT P10636 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 1/20 0.41
PKM P14618 1/20 0.41
NFKB1 P19838 1/20 0.41
MAOB P27338 1/20 0.41
RAB9A P51151 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
KMT2A Q03164 2/20 0.41
GRIN2B Q13224 3/20 0.40
ALDH1A1 P00352 4/20 0.40
CYP2D6 P10635 2/20 0.40
P2RY1 P47900 1/20 0.40
USP2 O75604 1/20 0.40
MAPK1 P28482 1/20 0.40
BCHE P06276 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5781699 0.70 GLA (0.39) MAPTSMN1; SMN2NPC1KMT2AALDH1A1
SCHEMBL5599176 0.70 GLA (0.39) MAPTSMN1; SMN2NPC1KMT2AALDH1A1
SCHEMBL5578994 0.67 MAPT (0.48) MAPTSMN1; SMN2NPC1PKMNFKB1
Hydrochloric Acid SCHEMBL7007458 0.67 NPY5R (0.49) CYP3A4ALDH1A1CYP2D6
SCHEMBL5599757 0.65 SIGMAR1 (0.40) CYP2C19CYP3A4MAPTSMN1; SMN2ALDH1A1
SCHEMBL5458965 0.63 MAPT (0.79) CYP2C19CYP3A4MAPTSMN1; SMN2NPC1
SCHEMBL31689287 0.62 GFER (0.53) MAPTSMN1; SMN2NPC1PKMNFKB1
SCHEMBL16860896 0.62 KDM1A (0.37) MAPK1
SCHEMBL5786199 0.61 SIGMAR1 (0.43) CYP2C19MAPTSMN1; SMN2PKMKMT2A
SCHEMBL2801668 0.60 NOTUM (0.40) KMT2ACYP2D6P2RY1MAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005063745-A9 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF ARENA PHARM INC (US) 2007-02-01 WO claimed